Rainey Carly A, Palmer Melissa C
Student, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri.
Clinical Assistant Professor, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri,
Ment Health Clin. 2020 Sep 30;10(5):301-304. doi: 10.9740/mhc.2020.09.301. eCollection 2020 Sep.
The objective of this data analysis was to assess the impact of the addition of a clinical psychiatric pharmacist to a community hospital inpatient psychiatric consult liaison team. Consult liaison psychiatry deals with medically ill patients in general hospital settings and involves the timely recognition and treatment of mental health conditions while coordinating with other medical providers. Each patient consulted to the psychiatry team was reviewed by the clinical pharmacist. Recommendations made by the clinical pharmacist were tracked over a 9-month period. During that time frame, 596 opportunities for intervention were identified. The largest proportion of identified opportunities for intervention were related to admission medication reconciliation, equating to roughly 30%. Optimization of safe medication use had the second largest number of opportunities for intervention at approximately 27%. Additional data, such as time spent on patient care, reason for consultation, and number of accepted recommendations based on medication class/type of intervention, were collected.
本次数据分析的目的是评估在社区医院住院精神科会诊联络团队中增加一名临床精神科药剂师的影响。会诊联络精神病学主要处理综合医院环境中患有躯体疾病的患者,涉及在与其他医疗服务提供者协作的同时,及时识别和治疗精神健康状况。临床药剂师会对每一位向精神科团队咨询的患者进行评估。临床药剂师给出的建议在9个月的时间内得到跟踪。在此期间,共确定了596个干预机会。已确定的干预机会中,最大比例与入院用药核对有关,约占30%。安全用药优化方面的干预机会数量次之,约为27%。此外,还收集了其他数据,如用于患者护理的时间、会诊原因以及基于药物类别/干预类型的接受建议数量。